Patents-Review.com
🔗 Permalink
Inventor profile of:

Birgit SCHOEBERL

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

24

Last publication date:

2024-03-28

Top Assignees for applications by Birgit SCHOEBERL

The entities that hold a legal rights for patent applications filed by inventor SCHOEBERL Birgit:

Recent patent applications by SCHOEBERL Birgit

Birgit SCHOEBERL from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-28
US20240101713A1
Chemistry; metallurgy

Bi-Specific Fusion Proteins

 #2 | 2023-10-12
US20230322951A1
Chemistry; metallurgy

Bi-Specific Fusion Proteins

 #3 | 2021-07-15
US20210214463A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #4 | 2021-02-11
US20210040233A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #5 | 2020-02-13
US20200048368A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #6 | 2018-08-23
US20180237540A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #7 | 2017-11-23
US20170335015A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #8 | 2017-10-26
US20170307631A1
Physics

METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE

 #9 | 2017-07-27
US20170210809A1
Chemistry; metallurgy

BISPECIFIC BINDING AGENTS TARGETING THE IGF-1R AND ERBB3 PATHWAYS AND USES THEREOF

 #10 | 2017-03-16
US20170073427A1
Chemistry; metallurgy

ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

 #11 | 2016-06-16
US20160168269A1
Chemistry; metallurgy

Method of treating myocardial infarction by administering a bi-specific fusion protein

 #12 | 2015-08-20
US20150231238A1
Human necessities

OVERCOMING RESISTANCE TO ERBB PATHWAY INHIBITORS

 #13 | 2014-08-21
US20140234329A1
Chemistry; metallurgy

Antibodies against the ectodomain of ERBB3 and uses thereof

 #14 | 2014-06-26
US20140178380A1
Human necessities

Bi-specific fusion proteins

 #15 | 2014-05-08
US20140127238A1
Physics

METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE

 #16 | 2012-09-27
US20120244163A1
Chemistry; metallurgy

BISPECIFIC BINDING AGENTS TARGETING IGF-1R AND ERBB3 SIGNALLING AND USES THEREOF

 #17 | 2011-12-01
US20110293579A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #18 | 2011-11-24
US20110286976A1
Chemistry; metallurgy

Bi-specific fusion proteins for tissue repair

 #19 | 2011-06-30
US20110159513A1
Human necessities

Methods and systems for predicting response of cells to a therapeutic agent

 #20 | 2011-05-26
US20110123523A1
Chemistry; metallurgy

Antibodies against ERBB3 and uses thereof

 #21 | 2011-02-03
US20110027291A1
Human necessities

METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE

 #22 | 2010-10-21
US20100266584A1
Chemistry; metallurgy

Antibodies against the ectodomain of ErbB3 and uses thereof

 #23 | 2010-03-04
US20100056761A1
Chemistry; metallurgy

ANTIBODIES AGAINST ERBB3 AND USES THEREOF

 #24 | 2009-11-26
US20090291085A1
Chemistry; metallurgy

Antibodies against ErbB3 and uses thereof
InventorID:

753583 ⎘